Amwell (AMWL) Reports Q4 Revenues Beat; Offers FY21 Revenue Mid-Point Outlook Below Consensus

Go back to Amwell (AMWL) Reports Q4 Revenues Beat; Offers FY21 Revenue Mid-Point Outlook Below Consensus
(NYSE: AMWL) Delayed: 9.11 -0.05 (0.55%)
Previous Close $9.16    52 Week High
Open $9.09    52 Week Low
Day High $9.31    P/E N/A 
Day Low $8.78    EPS
Volume 40,681